Trials of experimental HIV vaccine halted in Africa due to ineffectiveness

Anonymous HIV/AIDS Testing/ EPA-EFE/RUNGROJ YONGRIT

Trials of an experimental HIV vaccine in Uganda, Tanzania and South Africa were stopped early after preliminary data showed the vaccine would not be effective in preventing infection, the program's chief investigator said today.

It is the latest blow to efforts to find an effective vaccine against the virus, which has so far killed 40 million people worldwide. Another 39 million of them are living with HIV, most of them in Africa.

The vaccine trial, part of a wider initiative that began in December 2020 with 1.512 healthy people between the ages of 18 and 40, was due to end in 2024.

Dear reader,

Our access to web content is free, because we believe in equality in information, regardless of whether someone can pay or not. Therefore, in order to continue our work, we ask for the support of our community of readers by financially supporting the Free Press. Become a member of Sloboden Pechat to help the facilities that will enable us to deliver long-term and quality information and TOGETHER let's ensure a free and independent voice that will ALWAYS BE ON THE PEOPLE'S SIDE.

SUPPORT A FREE PRESS.
WITH AN INITIAL AMOUNT OF 60 DENARS

Video of the day